Aerosol Exposure of Cynomolgus Macaques to SARS-CoV-2 Results in More Severe Pathology than Existing Models

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

The emergence of SARS-CoV-2 pandemic has highlighted the need for animal models that faithfully recapitulate the salient features of COVID-19 disease in humans; these models are necessary for the rapid down-selection, testing, and evaluation of medical countermeasures. Here we performed a direct comparison of two distinct routes of SARS-CoV-2 exposure, combined intratracheal/intranasal and small particle aerosol, in two nonhuman primate species: rhesus and cynomolgus macaques. While all four experimental groups displayed very few outward clinical signs, evidence of mild to moderate respiratory disease was present on radiographs and at the time of necropsy. Cynomolgus macaques exposed via the aerosol route also developed the most consistent fever responses and had the most severe respiratory disease and pathology. This study demonstrates that while all four models were suitable representations of mild COVID-like illness, aerosol exposure of cynomolgus macaques to SARS-CoV-2 produced the most severe disease, which may provide additional clinical endpoints for evaluating therapeutics and vaccines.

Article activity feed

  1. SciScore for 10.1101/2021.04.27.441510: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    EthicsField Sample Permit: Study approval: Research was conducted under an IACUC-approved protocol in compliance with the Animal Welfare Act, PHS Policy, and other Federal statutes and regulations relating to animals and experiments involving animals.
    Sex as a biological variableNHPs: The study used eight healthy cynomolgus macaques and eight healthy rhesus macaques with equal distribution of sex among the groups (n=8 males and n=8 females; n=2 of each per group).
    RandomizationVirus exposure: Animals were randomized to exposure route balanced by sex and weight.
    Blindingnot detected.
    Power Analysisnot detected.
    Cell Line AuthenticationContamination: The production stock underwent additional testing to evaluate sterility, mycoplasma and endotoxin levels, as well as a number of real-time reverse transcriptase polymerase chain reaction (RT-PCR) assays for exclusivity and inclusivity, to include two specific for SARS-CoV-2 virus.

    Table 2: Resources

    Antibodies
    SentencesResources
    Then the sections were incubated with primary antibodies: rabbit anti-SARS-CoV Spike (1:200, 40150-T62-COV2, Sino Biological, Chesterbrook, PA, USA)
    anti-SARS-CoV
    suggested: (Rockland Cat# 200-401-A51, RRID:AB_828457)
    , rabbit anti-CD3 (1:200, A045229-2, Dako Agilent Pathology Solutions, Carpinteria, CA, USA), rabbit anti-MPO (1:200, A039829-2, Dako Agilent Pathology Solutions, Carpinteria, CA, USA), rabbit anti-CD68 (1:200, ab125047, Abcam, Cambridge, MA, USA), mouse anti-CD68 (1:100, M081401-2, Dako Agilent Pathology Solutions)
    anti-MPO
    suggested: None
    anti-CD68
    suggested: (Abcam Cat# ab125047, RRID:AB_10971844)
    , Thermo Fisher Scientific) and goat anti-mouse Alexa Fluor 568 (red, 1:500, Thermo Fisher Scientific) antibodies, for 1 hour at room temperature.
    anti-mouse
    suggested: None
    Experimental Models: Cell Lines
    SentencesResources
    The CDC isolate had been passaged three times in CCL-81 cells prior to receipt at the USAMRIID lab.
    CCL-81
    suggested: None
    Plaque assay: A neutral red plaque assay using ATCC Vero 76 cells was performed on the virus stock, AGIs from the AE-exposed animals, and nasopharyngeal and oropharyngeal swab lysates as previously described (13).
    Vero 76
    suggested: IZSLER Cat# BS CL 101, RRID:CVCL_0603)
    Software and Algorithms
    SentencesResources
    Images were captured on a Zeiss LSM 880 confocal system (Zeiss, Oberkochen, Germany) and processed using ImageJ software (National Institutes of Health, Bethesda,
    ImageJ
    suggested: (ImageJ, RRID:SCR_003070)
    Statistics: All analyses were performed using GraphPad Prism 9.
    GraphPad Prism
    suggested: (GraphPad Prism, RRID:SCR_002798)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on page 24. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    Results from scite Reference Check: We found no unreliable references.


    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.